AptarGroup stock
Price history
+18.13% over the period1 year: from $118.58 (November 20, 2025) to $140.08 (November 20, 2026), +18.13%.
Show chart data
Closing prices adjusted for splits: the last close of each month.
| Date | Close |
|---|---|
| November 20, 2026 | $140.08 |
| October 30, 2026 | $137.20 |
| September 30, 2026 | $121.16 |
| August 31, 2026 | $131.62 |
| July 31, 2026 | $133.96 |
| June 30, 2026 | $125.20 |
| May 29, 2026 | $115.85 |
| April 30, 2026 | $123.68 |
| March 31, 2026 | $126.02 |
| February 27, 2026 | $143.71 |
| January 30, 2026 | $124.95 |
| December 31, 2025 | $121.96 |
| November 28, 2025 | $124.75 |
| November 20, 2025 | $118.58 |
At a glance
The company
Designs and manufactures drug delivery systems, dispensing solutions and active material science products for pharmaceutical, beauty and consumer goods markets
Latest results
Quarter to September 30, 2026 · EPS $1.52 (estimate $1.47)
TickerLandia's take on AptarGroup
- Cheaper than usual relative to earnings: P/E on the latest fiscal year 24 vs a median of 30 over its last 10 fiscal years.
- Priced in line with similar companies: trailing 12-month P/E 34 vs 34 (+0%) in a group of 9.
- Strong point: Market momentum (78/100 in its group). Weak point: Growth (31/100).
Analysis calculated by TickerLandia from financial statements and prices, with public rules. Not investment advice. How we analyse stocks
Where the price stands
−5.75% from the 52-week high
Analysts · 9 analysts
Average target$163.88+16.99% vs. price
Buy 7 · Hold 2 · Sell 0
TickerLandia Fingerprint: AptarGroup
Compared with similar companies: strong momentum, high earnings stability, and low risk.
Financials and price compared with 34 companies in the medical instruments & supplies industry, worldwide. Momentum and risk compared with 888 North American stocks.
Priceaverage43
How much it costs relative to what it produces.
Metric Value Position in group P/E (trailing 12 months) 33.8 48 Forward P/E 22.6 57 EV/EBITDA 12.6 25 Price/book 3.40 51 Price/sales 2.22 34 Profitabilitylow39
How much it earns on revenue and capital.
Metric Value Position in group Operating margin 12.4% 34 Gross margin 35.8% 19 Net margin 6.7% 43 ROA 6.0% 51 ROE 9.8% 46 Earnings stabilityhigh75
How steady its margins were over the last five annual reports.
Metric Value Position in group Margin variabilitycounts in reverse: lower means more earnings stability 1.3% 87 Loss-making yearscounts in reverse: lower means more earnings stability 0 of 5 annual reports 63 Growthlow31
How fast revenue and earnings are growing.
Metric Value Position in group Revenue growth (year over year) +6.00% 54 Earnings growth (year over year) −73.40% 2 Average revenue growth (3 years) +4.37% 37 Financial strengthaverage49
How well it would weather a hard period: debt, liquidity, interest.
Metric Value Position in group Current ratio 1.50 40 Debt/equitycounts in reverse: lower means more financial strength 0.53 38 Interest coverage 9.79 72 Net debt/EBITDAcounts in reverse: lower means more financial strength 1.20 45 Dividendhigh69
How much it returns to shareholders, and for how long.
Metric Value Position in group Payout ratio 46.9% 60 Dividend yield 1.4% 59 Consecutive dividend years at least 34 years 87 Market momentumstrong78
How the stock has moved compared with the market.
Metric Value Position in group Relative strength (3 months) +16.50% 81 Distance from 200-day average +9.20% 80 1-year return +18.13% 64 Relative strength (6 months) +30.72% 86 Risklow29
How much the price swings.
Metric Value Position in group Volatility (60 days) 23.5% 18 Beta (1 year) 0.38 34 Maximum drawdown (12 months) 23.2% 34
Position in the group from 0 to 100 (100 = highest value): it describes, it does not rate. Tap a row for the metrics. Calculated on November 22, 2026. An indicator calculated by TickerLandia from financial statements and market data. How it is calculated
Valuation
AptarGroup is cheaper than in the past and in line with similar companies
On the latest fiscal year's earnings (2025), AptarGroup's P/E today is 23.8, below the median of its last 10 fiscal years (29.9; between 20.7 and 42.6 from 2016 to 2025). AptarGroup's P/E (trailing 12 months): 33.8, in line with the median of a group of 9 similar companies (33.8).
Compared with 9 similar companies
| Metric | AptarGroup | Position in the group | Band |
|---|---|---|---|
| P/E (trailing 12 months) | 33.8 | Middle | |
| Forward P/E | 22.6 | Middle | |
| Operating margin | 12.4% | Middle | |
| ROE | 9.8% | Middle | |
| Debt/equity | 0.53 | Middle |
P/E at fiscal year end; today on the latest fiscal year's earnings. Grey band: the middle half of the group; tick: the median; dot: AptarGroup. All multiples and dividends
TickerLandia analysisHow it is calculated
The financials
The business in numbers
Revenue
$1.02B
Latest quarter · Q3 2026
Net income
$32.6M
Latest quarter · Q3 2026
Quarterly net margin
3.2%
Latest quarter · Q3 2026
Numbers and valuation
Full valuation- Market cap
- $8.88B
- P/E
- 33.8
- EPS
- $4.14
- Volume
- 868.1K
- Daily trading
- €73M
- Dividend yield
- 1.38%
- Last ex-dividend on November 12, 2026
How AptarGroup is changing
All resultsRevenue grew 5.2% a year on average over the last 5 years
Operating margin rose from 11.4% to 13.3%
Free cash flow equal to 88% of net income
Returns
AptarGroup returns with dividends
$1,000 invested in AptarGroup 5 years ago, on November 22, 2021, would be worth $1,162 today with dividends reinvested: +16.21% in total, +3.05% per year. On price alone it would be $1,088 (+8.76%).
| Period | AptarGroup | S&P 500 | $1,000 becomes |
|---|---|---|---|
| 1 month | +11.38% | −10.40% | $1,114 |
| 6 months | +21.53% | −7.03% | $1,215 |
| Year to date | +14.86% | +0.95% | $1,149 |
| 1 year | +19.88% | +5.68% | $1,199 |
| 3 years | +14.39% | +51.96% | $1,144 |
| 5 years | +16.21% | +47.57% | $1,162 |
| 10 years | +115.28% | +214.37% | $2,153 |
Over the last 6 months it has done better than 68% of the stocks in the Healthcare sector.
From 1 year up with dividends reinvested, before taxes; under a year price only. S&P 500: price only. Calculate your investment
The chart in detail
AptarGroup: technical analysis
AptarGroup is in an uptrend: the price is above its 50- and 200-session moving averages, and the 200-session average is rising. The price is 20.5% below its all-time closing high ($176.15, November 11, 2024).
- Trend
- Upward
- RSI (14 sessions)
- 58
- Between 30 and 70
- vs 200-session average
- +9.20%
Active signals
Golden cross: the 50-session average has crossed above the 200-session average.
since November 13, 2026
Support and resistance
Price areas where AptarGroup has stopped several times in the last year. They describe the chart; they are not forecasts.
- Resistance$147.77+5.49%2 touches, last on November 5, 2026
- Last price$140.08
- Support$136.64−2.45%2 touches, last on August 26, 2026
- Support$127.16−9.23%6 touches, last on September 16, 2026
- Support$123.82−11.61%2 touches, last on July 8, 2026
Volatility and risk
Over the last year it has moved little with the S&P 500.
- Beta (1 year) vs S&P 500
- 0.38
- Volatility (60 sessions, annualised)
- 23.5%
- Largest fall in the last year
- −23.18%
Close of November 20, 2026. Descriptive data calculated on daily prices: it describes the chart and is not investment advice. Beta and volatility describe the last year and can change a lot from one year to the next. How we calculate it
AptarGroup: seasonality
Average monthly price change over 34 years
Over the last 34 years, the strongest month for AptarGroup has been November: +3.92% on average, positive in 27 years out of 33. The weakest has been September: −1.78% on average, positive in 14 years out of 34.
Show chart data
| Month | Average | Median | Positive years |
|---|---|---|---|
| January | −1.77% | −0.33% | 15 of 33 |
| February | +3.08% | +2.63% | 25 of 33 |
| March | +2.18% | +2.13% | 24 of 33 |
| April | +2.50% | +3.64% | 23 of 33 |
| May | +1.01% | +1.67% | 22 of 34 |
| June | −0.76% | +0.58% | 18 of 34 |
| July | +1.43% | +2.06% | 20 of 34 |
| August | +0.79% | +0.86% | 18 of 34 |
| September | −1.78% | −1.64% | 14 of 34 |
| October | +0.99% | +0.83% | 21 of 34 |
| November | +3.92% | +3.75% | 27 of 33 |
| December | +1.26% | +0.45% | 20 of 33 |
Price change only, dividends excluded. Past seasonality does not predict future moves.
The company
AptarGroup and its competitors
Europe generates the largest share of sales for AptarGroup, Inc., at 49.3%, followed by North America at 31.1%, Asia at 11.8% and Latin America at 7.8%. The group designs and makes dispensers, pumps and closures, along with valves and elastomeric components for packaging, serving drug makers, perfume houses, skincare and cosmetics brands, household and personal care producers, and food and beverage companies. Its activities are organized into Pharma, Beauty and Closures, and it also supplies digital health tools and active material science offerings.
- Headquarters
- Crystal Lake, United States
- Employees
- 14,000
- Founded
- 1992
- Chief executive
- Gael Touya
| Company | Market cap | Operating margin | P/E (trailing 12 months) | 6 months |
|---|---|---|---|---|
| AptarGroupATR | $8.88B | 12.4% | 33.8 | +21.53% |
| AvantorAVTR | $10.06B | 8.0% | 29.7 | +88.32% |
| RepligenRGEN | $10.89B | 8.1% | — | +46.60% |
| Align TechnologyALGN | $10.94B | 19.6% | 22.6 | −5.03% |
| Cooper CompaniesCOO | $11.2B | 12.9% | 20.2 | −4.65% |
| Baxter InternationalBAX | $13.14B | 7.6% | — | +35.27% |
Same industry or related industries, similar size. Compare AptarGroup with its competitors · Full profile
